Ampio Pharmaceuticals, Inc. Gains 29.51%
Thu, Mar 24, 2022 at 05:30 PM
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) rocketted at $0.56, representing a gain of 29.5%. The stock got featured on our News Catalysts scanner on Wed, Mar 23, 2022 at 09:29 AM in the 'EARNINGS' category. From Wed, Mar 09, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 39.07%
- Global Internet of People Inc. (SDH:NASDAQ), 38.35%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 34.89%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 33.67%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 32.82%
- Emclaire Financial Corp (EMCF:NASDAQ), 32.17%
- cbdMD, Inc. (YCBD:NYSEMKT), 31.33%
- NexImmune Inc. (NEXI:NASDAQ), 31.06%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 30.48%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 29.51%